Measures to Increase the Effectiveness of Fast Track Colorectal Clinics for Iron Deficiency Anaemia.
NCT ID: NCT03988712
Last Updated: 2019-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
950 participants
OBSERVATIONAL
2018-04-01
2019-02-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the study, patients with true IDA (low MCV and ferritin) were found to be more likely to have Colorectal cancer compared to any other type of anaemia which confirmed the latest guidelines for management of IDA. Compared to symptoms, only the presence of a mass on abdominal examination and rectal examination was found to be more likely associated with cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fatigue, Quality of Life, Cognitive Function and Physical Ability in Patients Suspected of Colorectal Malignancy
NCT04749589
Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients.
NCT05221957
Preoperative i.v. Iron Substitution in Patients With Colon Cancer
NCT04653181
Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer
NCT05220800
Usefulness of Fecal Immunochemical Test in Iron Deficiency Anemia (IDAFIT)
NCT02792023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigator's hypothesis was that patients with IDA are more likely to have CRC compared to patients with no anaemia or non-IDA anaemia. By confirming this hypothesis, Investigators can identify high risk patients from the population who can then be preferentially subjected to investigations mandated by guidelines. This strategy can help to increase the diagnostic yield of FT CRC clinics.
A retrospective cohort study was conducted from 2016-18 in a single busy district general hospital providing services to a population of 700,000 people.
In the study, patients with true IDA (low MCV and ferritin) were found to be more likely to have CRC compared to any other type of anaemia which confirmed the latest guidelines for management of IDA. Compared to symptoms, only the presence of a mass on abdominal examination and rectal examination was found to be more likely associated with cancer.
Physicians should be able to stratify patients based on blood indices when referring them to FT CRC clinics. Diagnostic yield of these clinics can be increased if clinicians strictly adhere to fast track guidelines and confirm true IDA before referring patients to clinic.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Iron deficiency anaemia with bowel symptoms
Patients with IDA presenting with bowel symptoms like change in bowel habits, weight loss and abdominal mass other than rectal bleed
Colonoscopy, gastroscopy, virtual colonoscopy, CT scan
Patients referred with a suspected bowel malignancy were subjected to top and bottom endoscopic examination or a cross sectional imaging like CT scan and MRI scan.
Iron deficiency anaemia with no bowel symptoms
Patients with IDA with no bowel symptoms
Colonoscopy, gastroscopy, virtual colonoscopy, CT scan
Patients referred with a suspected bowel malignancy were subjected to top and bottom endoscopic examination or a cross sectional imaging like CT scan and MRI scan.
Iron deficiency anaemia with rectal bleeding
Patients with IDA and rectal bleeding
Colonoscopy, gastroscopy, virtual colonoscopy, CT scan
Patients referred with a suspected bowel malignancy were subjected to top and bottom endoscopic examination or a cross sectional imaging like CT scan and MRI scan.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colonoscopy, gastroscopy, virtual colonoscopy, CT scan
Patients referred with a suspected bowel malignancy were subjected to top and bottom endoscopic examination or a cross sectional imaging like CT scan and MRI scan.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. With bowel symptoms
2. Presenting with anaemia
3. Rectal bleeding
Exclusion Criteria
1. With bowel symptoms
2. Presenting with anaemia
3. Rectal bleeding Aged less than 18 years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wirral University Teaching Hospital NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mr Talal Majeed
Research Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
TALAL MAJEED, MRCS
Role: PRINCIPAL_INVESTIGATOR
Mr Talal Majeed
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
York Hospital
York, Yorkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
161130
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.